Comparative analysis of interactions of RASSF1-10

Advances in Biological Regulation

Volumn 53, Issue 2, 2013, Pages 190-201

  Chan, Jia Jia ^a   Flatters, Delphine ^b   Rodrigues Lima, Fernando ^b   Yan, Jun ^a   Thalassinos, Konstantinos ^a   Katan, Matilda ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84878572955     PISSN: 22124926     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.jbior.2012.12.001     Document Type: Article

References (39)

1. Akino K., Toyota M., Suzuki H., Mita H., Sasaki Y., Ohe-Toyota M., et al. The ras effector RASSF2 is a novel tumor-suppressor gene in human colorectal cancer. Gastroenterology 2005, 129:156-169.
2. Allen N.P., Donninger H., Vos M.D., Eckfeld K., Hesson L., Gordon L., et al. RASSF6 is a novel member of the RASSF family of tumor suppressors. Oncogene 2007, 26:6203-6211.
3. Avruch J., Praskova M., Ortiz-Vega S., Liu M., Zhang X.F. Nore1 and RASSF1 regulation of cell proliferation and of the MST1/2 kinases. Methods in Enzymology 2006, 407:290-310.
4. Bunney T.D., Esposito D., Mas-Droux C., Lamber E., Baxendale R.W., Martins M., et al. Structural and functional integration of the PLCgamma interaction domains critical for regulatory mechanisms and signaling deregulation. Structure 2012, 20:2062-2075.
5. Bunney T.D., Harris R., Gandarillas N.L., Josephs M.B., Roe S.M., Sorli S.C., et al. Structural and mechanistic insights into ras association domains of phospholipase C epsilon. Molecular Cell 2006, 21:495-507.
6. Burbee D.G., Forgacs E., Zöchbauer-Müller S., Shivakumar L., Fong K., Gao B., et al. Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression. Journal of National Cancer Institute 2001, 93:691-699.
7. Constantinescu Aruxandei D., Makbul C., Koturenkiene A., Ludemann M.B., Herrmann C. Dimerization-induced folding of MST1 SARAH and the influence of the intrinsically unstructured inhibitory domain: low thermodynamic stability of monomer. Biochemistry 2011, 50:10990-11000.
8. Cooper W.N., Dickinson R.E., Dallol A., Grigorieva E.V., Pavlova T.V., Hesson L.B., et al. Epigenetic regulation of the ras effector/tumour suppressor RASSF2 in breast and lung cancer. Oncogene 2008, 27:1805-1811.
9. Cooper W.N., Hesson L.B., Matallanas D., Dallol A., von Kriegsheim A., Ward R., et al. RASSF2 associates with and stabilizes the proapoptotic kinase MST2. Oncogene 2009, 28:2988-2998.
10. Dallol A., Hesson L.B., Matallanas D., Cooper W.N., O'Neill E., Maher E.R., et al. RAN GTPase is a RASSF1A effector involved in controlling microtubule organization. Current Biology 2009, 19:1227-1232.
11. Dammann R., Li C., Yoon J.H., Chin P.L., Bates S., Pfeifer G.P. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. Nature Genetics 2000, 25:315-319.
12. Dittfeld C., Richter A.M., Steinmann K., Klagge-Ulonska A., Dammann R.H. The SARAH domain of RASSF1A and its tumor suppressor function. Molecular Biology International 2012, 2012:196715.
13. Downward J. Targeting RAS signalling pathways in cancer therapy. Nature Reviews Cancer 2003, 3:11-22.
14. Eckfeld K., Hesson L., Vos M.D., Bieche I., Latif F., Clark G.J. RASSF4/AD037 is a potential ras effector/tumor suppressor of the RASSF family. Cancer Research 2004, 64:8688-8693.
15. Eswar N., Webb B., Marti-Renom M.A., Madhusudhan M.S., Eramian D., Shen M.Y., et al. Comparative protein structure modeling using Modeller. Current Protocol in Bioinformatics 2006, 15:5.6.1-5.6.30.
16. Huang L., Hofer F., Martin G.S., Kim S.H. Structural basis for the interaction of Ras with RalGDS. Nature Structural Biology 1998, 5:422-426.
17. Hwang E., Ryu K.S., Paakkonen K., Guntert P., Cheong H.K., Lim D.S., et al. Structural insight into dimeric interaction of the SARAH domains from Mst1 and RASSF family proteins in the apoptosis pathway. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:9236-9241.
18. Ikeda M., Hirabayashi S., Fujiwara N., Mori H., Kawata A., Iida J., et al. Ras-association domain family protein 6 induces apoptosis via both caspase-dependent and caspase-independent pathways. Experimental Cell Research 2007, 313:1484-1495.
19. Ikeda M., Kawata A., Nishikawa M., Tateishi Y., Yamaguchi M., Nakagawa K., et al. Hippo pathway-dependent and -independent roles of RASSF6. Science Signaling 2009, 2:ra59.
20. Khokhlatchev A., Rabizadeh S., Xavier R., Nedwidek M., Chen T., Zhang X.-F., et al. Identification of a novel Ras-regulated proapoptotic pathway. Current Biology 2002, 12:253-265.
21. Kiel C., Foglierini M., Kuemmerer N., Beltrao P., Serrano L. A genome-wide Ras-effector interaction network. Journal of Biological Chemistry 2007, 370:1020-1032.
22. Kiel C., Selzer T., Shaul Y., Schreiber G., Herrmann C. Electrostatically optimized Ras-binding Ral guanine dissociation stimulator mutants increase the rate of association by stabilizing the encounter complex. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:9223-9228.
23. Lupas A. Coiled coils: new structures and new functions. Trends in Biochemical Sciences 1996, 21:375-382.
24. Macheiner D., Gauglhofer C., Rodgarkia-Dara C., Grusch M., Brachner A., Bichler C., et al. NORE1B is a putative tumor suppressor in hepatocarcinogenesis and may act via RASSF1A. Cancer Research 2009, 69:235-242.
25. Miertzschke M., Stanley P., Bunney T.D., Rodrigues-Lima F., Hogg N., Katan M. Characterization of interactions of adapter protein RAPL/Nore1B with RAP GTPases and their role in T cell migration. Journal of Biological Chemistry 2007, 282:30629-30642.
26. Nassar N., Horn G., Herrmann C., Block C., Janknecht R., Wittinghofer A. Ras/Rap effector specificity determined by charge reversal. Nature Structural Biology 1996, 3:723-729.
27. Ortiz-Vega S., Khokhlatchev A., Nedwidek M., Zhang X.-F., Dammann R., Pfeifer G.P., et al. The putative tumor suppressor RASSF1A homodimerizes and heterodimerizes with the Ras-GTP binding protein Nore1. Oncogene 2002, 21:1381-1390.
28. Pfeifer G.P., Dammann R. Methylation of the tumor suppressor gene RASSF1A in human tumors. Biochemistry 2005, 70:576-583.
29. Praskova M., Khoklatchev A., Ortiz-Vega S., Avruch J. Regulation of the MST1 kinase by autophosphorylation, by the growth inhibitory proteins, RASSF1 and NORE1, and by Ras. Biochemical Journal 2004, 381:453-462.
30. Pringle S.D., Giles K., Wildgoose J.L., Williams J.P., Slade S.E., Thalassinos K., et al. An investigation of the mobility separation of some peptide and protein ions using a new hybrid quadrupole/travelling wave IMS/oa-ToF instrument. International Journal of Mass Spectrometry 2007, 261:1-12.
31. Richter A.M., Pfeifer G.P., Dammann R.H. The RASSF proteins in cancer; from epigenetic silencing to functional characterization. Biochimica et Biophysica Acta 2009, 1796:114-128.
32. Rodriguez-Viciana P., Sabatier C., McCormick F. Signaling specificity by Ras family GTPases is determined by the full spectrum of effectors they regulate. Molecular and Cellular Biology 2004, 24:4943-4954.
33. Scheel H., Hofmann K. A novel inter action motif, SARAH, connects three classes of tumor suppressor. Current Biology 2003, 13:R899-R900.
34. Stieglitz B., Bee C., Schwarz D., Yildiz O., Moshnikova A., Khokhlatchev A., et al. Novel type of Ras effector interaction established between tumour suppressor NORE1A and Ras switch II. EMBO Journal 2008, 27:1995-2005.
35. Takahashi S., Ebihara A., Kajiho H., Kontani K., Nishina H., Katada T. RASSF7 negatively regulates pro-apoptotic JNK signaling by inhibiting the activity of phosphorylated-MKK7. Cell Death & Differentiation 2011, 18:645-655.
36. Vos M.D., Ellis C.A., Bell A., Birrer M.J., Clark G.J. Ras uses the novel tumor suppressor RASSF1 as an effector to mediate apoptosis. Journal of Biological Chemistry 2000, 275:35669-35672.
37. Vos M.D., Ellis C.A., Elam C., Ulku A.S., Taylor B.J., Clark G.J. RASSF2 is a novel K-Ras-specific effector and potential tumor suppressor. Journal of Biological Chemistry 2003, 278:28045-28051.
38. Vos M.D., Martinez A., Ellis C.A., Vallecorsa T., Clark G.J. The pro-apoptotic Ras effector Nore1 may serve as a Ras-regulated tumor suppressor in the lung. Journal of Biological Chemistry 2003, 278:21938-21943.
39. Xu D., Zhang Y. Ab initio protein structure assembly using continuous structure fragments and optimized knowledge-based force field. Proteins 2012, 80:1715-1735.